Kim Popovits, Hakan Sakul

The Personalized Medicine Coalition has elected two new board members, Genomic Health CEO Kim Popovits and Hakan Sakul, head of diagnostics at Pfizer. Popovits and Sakul are joining PMC's board as the terms for two current members — Felix Frueh of Human Longevity and Jeffrey Cossman, formerly of United States Diagnostic Standards — expire.


David Jaffe

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.